Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans

J Math Biol. 2023 Apr 30;86(5):86. doi: 10.1007/s00285-023-01919-3.

Abstract

A compartment model for an in-host liquid nanoparticle delivered mRNA vaccine is presented. Through non-dimensionalisation, five timescales are identified that dictate the lifetime of the vaccine in-host: decay of interferon gamma, antibody priming, autocatalytic growth, antibody peak and decay, and interleukin cessation. Through asymptotic analysis we are able to obtain semi-analytical solutions in each of the time regimes which allows us to predict maximal concentrations and better understand parameter dependence in the model. We compare our model to 22 data sets for the BNT162b2 and mRNA-1273 mRNA vaccines demonstrating good agreement. Using our analysis, we estimate the values for each of the five timescales in each data set and predict maximal concentrations of plasma B-cells, antibody, and interleukin. Through our comparison, we do not observe any discernible differences between vaccine candidates and sex. However, we do identify an age dependence, specifically that vaccine activation takes longer and that peak antibody occurs sooner in patients aged 55 and greater.

Keywords: In-host modelling; MRNA-based vaccines; Model reduction; Vaccines; Waning immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies
  • Antibodies, Viral
  • BNT162 Vaccine*
  • Epidemiological Models
  • Humans
  • RNA, Messenger / genetics
  • mRNA Vaccines*

Substances

  • BNT162 Vaccine
  • mRNA Vaccines
  • Antibodies
  • RNA, Messenger
  • Antibodies, Viral